Search Results - "Enzyme Inhibitors therapeutic use"
-
1
Authors: et al.
Source: Circulation. 151:931-945
Subject Terms: Heart Failure, Male, Sweden, Adrenergic beta-Antagonists, beta-blockers, heart failure, mineralocorticoid receptor antagonists, registries, renin-angiotensin system, withholding treatment, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Middle Aged, Heart Failure/drug therapy, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Sweden/epidemiology, Treatment Outcome, Withholding Treatment, Practice Guidelines as Topic, Stroke Volume/drug effects, Humans, Female, Registries, Aged, Retrospective Studies, Mineralocorticoid Receptor Antagonists
Access URL: https://pubmed.ncbi.nlm.nih.gov/40091747
https://research.rug.nl/en/publications/977f7b17-c48a-46eb-8762-f282ec0b9907
https://hdl.handle.net/11370/977f7b17-c48a-46eb-8762-f282ec0b9907
https://doi.org/10.1161/CIRCULATIONAHA.124.072855
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.072855
https://doi.org/10.1161/circulationaha.124.072855 -
2
Authors: et al.
Contributors: et al.
Source: The American journal of cardiology, vol. 230, pp. 27-36
Subject Terms: Adult, Heart Defects, Congenital, Humans, Female, Pregnancy, Registries, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists/therapeutic use, Pregnancy Complications, Cardiovascular/drug therapy, Pregnancy Complications, Cardiovascular/epidemiology, Prospective Studies, Pregnancy Outcome/epidemiology, Heart Diseases/epidemiology, Abnormalities, Drug-Induced/epidemiology, Heart Defects, Congenital/epidemiology, ACE inhibitor, angiotensin receptor blocker, preconception, pregnancy, Heart Diseases, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Abnormalities, Drug-Induced, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39122205
https://pure.eur.nl/en/publications/0e29ca3f-0215-45f3-8b9f-b2fa41044a27
https://doi.org/10.1016/j.amjcard.2024.08.004
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_6983B349F8872
https://serval.unil.ch/resource/serval:BIB_6983B349F887.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_6983B349F887 -
3
Authors: Kaschina, Elena
Source: Hypertens Res
Subject Terms: Renin-Angiotensin System, Comment, Hypertension, RAAS, Renin-Angiotensin System/drug effects [MeSH], Humans [MeSH], Hypertension/physiopathology [MeSH], Losartan, Angiotensin-Converting Enzyme Inhibitors/therapeutic use [MeSH], Exercise/physiology [MeSH], Exercise, Hypertension/drug therapy [MeSH], SHR, Angiotensin-Converting Enzyme Inhibitors/pharmacology [MeSH], Renin-Angiotensin System/physiology [MeSH], Antihypertensive Agents/therapeutic use [MeSH], comment, Humans, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents
-
4
Authors: Ferreira,Ana Carina
Source: Portuguese Kidney Journal (PKJ) v.38 n.3-4 2024
Subject Terms: Renal Insufficiency, Chronic/drug therapy, Kidney Failure, Chronic/drug therapy, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin‑Converting Enzyme Inhibitors/therapeutic use
File Description: text/html
-
5
Authors: et al.
Source: Larsen, A H, Lauridsen, T K, Vishram-Nielsen, J, Vase, H, Vraa, S, Wolsk, E, Barasa, A, Søholm, H, Køber, L & Dridi, N P 2024, 'Ætiologi og behandling af kronisk hjertesvigt med nedsat venstre ventrikelfunktion', Ugeskrift for Læger, bind 186, V05240339. https://doi.org/10.61409/V05240339
Larsen, A H, Lauridsen, T K, Vishram-Nielsen, J, Vase, H, Vraa, S, Wolsk, E, Barasa, A, Søholm, H, Køber, L & Dridi, N P 2024, 'Ætiologi og behandling af kronisk hjertesvigt med nedsat venstre ventrikelfunktion', Ugeskrift for Læger, bind 186, nr. 42. https://doi.org/10.61409/V05240339Subject Terms: Mineralocorticoid Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Chronic Disease, Humans, Stroke Volume, Heart Failure/drug therapy, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists/therapeutic use, Ventricular Dysfunction, Left/drug therapy
File Description: application/pdf
Access URL: https://vbn.aau.dk/da/publications/6baf781b-56cc-49d2-8bbb-4703e250136e
https://vbn.aau.dk/ws/files/753430395/Larsen_et_al._2024_._tiologi_og_behandling_af_kronisk_hjertesvigt_med_nedsat_venstre_ventrikelfunktion.pdf
https://doi.org/10.61409/V05240339
http://www.scopus.com/inward/record.url?scp=85209479845&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/50d9be2e-5936-46c1-b550-7d1dc5a45d4d
https://doi.org/10.61409/V05240339
http://www.scopus.com/inward/record.url?scp=85209479845&partnerID=8YFLogxK -
6
Authors: et al.
Contributors: et al.
Source: New England Journal of Medicine. 389:710-721
Subject Terms: Lung Neoplasms/genetics, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung/drug therapy, KRAS protein, human, Oncologie, Administration, Oral, Antineoplastic Agents, Sciences de la santé humaine, Proto-Oncogene Proteins p21(ras)/genetics, Proto-Oncogene Proteins p21(ras), Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung, Genetics, Humans, Human health sciences, Enzyme Inhibitors, Non-Small-Cell Lung, Lung Neoplasms/drug therapy, Treatments in Oncology, Cancer, Enzyme Inhibitors/therapeutic use, Pulmonary/Critical Care General, Medicine (all), Carcinoma, Lung Cancer, Antineoplastic Agents/therapeutic use, Gastroenterology, Colorectal Neoplasms/drug therapy, Antineoplastic Agents/adverse effects, General Medicine, Enzyme Inhibitors/adverse effects, Hematology/Oncology, Colorectal Neoplasms/genetics, Antineoplastic Agents/administration & dosage, 3. Good health, Pulmonary/Critical Care, Oncology, Enzyme Inhibitors/administration & dosage, Mutation, Colorectal Neoplasms, Gastrointestinal Tract Cancer
-
7
Authors: et al.
Contributors: et al.
Source: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
New England Journal of Medicine, vol 389, iss 7Subject Terms: Biomedical and clinical sciences, Glioma / genetics, Pyridines, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Antineoplastic Agents, Medical and Health Sciences, Neoplasm Recurrence, Local / drug therapy, Pyridines / adverse effects, Rare Diseases, Double-Blind Method, Clinical Research, General & Internal Medicine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Enzyme Inhibitors / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Humans, Enzyme Inhibitors, Cancer, Isocitrate Dehydrogenase / genetics, Biomedical and Clinical Sciences, Neurosciences, INDIGO Trial Investigators, Health sciences, Glioma, Antineoplastic Agents / therapeutic use, Isocitrate Dehydrogenase, 3. Good health, Brain Disorders, Brain Cancer, Neoplasm Recurrence, Local, 6.1 Pharmaceuticals, Glioma / drug therapy, Disease Progression, Neoplasm Recurrence, Local
File Description: application/pdf
-
8
Authors: et al.
Contributors: et al.
Source: European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Metra, M, Tomasoni, D, Adamo, M, Bayes-Genis, A, Filippatos, G, Abdelhamid, M, Adamopoulos, S, Anker, S D, Antohi, L, Böhm, M, Braunschweig, F, Gal, T B, Butler, J, Cleland, J G F, Cohen-Solal, A, Damman, K, Gustafsson, F, Hill, L, Jankowska, E A, Lainscak, M, Lund, L H, McDonagh, T, Mebazaa, A, Moura, B, Mullens, W, Piepoli, M, Ponikowski, P, Rakisheva, A, Ristic, A, Savarese, G, Seferovic, P, Sharma, R, Tocchetti, C G, Yilmaz, M B, Vitale, C, Volterrani, M, von Haehling, S, Chioncel, O, Coats, A J S & Rosano, G 2023, ' Worsening of chronic heart failure : definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology ', European Journal of Heart Failure, vol. 25, no. 6, pp. 776-791 . https://doi.org/10.1002/ejhf.2874Subject Terms: Heart Failure, Emergency department visits, Adrenergic beta-Antagonists, Worsening heart failure, Cardiology, Diuretics/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Intensification of oral therapy, Adrenergic beta-Antagonists/therapeutic use, Prognosis, 3. Good health, Hospitalization, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Outpatients, Chronic Disease, Quality of Life, Humans, Heart Failure/epidemiology, Diuretics
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37208936
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11846
https://hdl.handle.net/11588/921932
https://research.rug.nl/en/publications/d1f74743-3722-4693-873e-a880a72b3327
https://hdl.handle.net/11370/d1f74743-3722-4693-873e-a880a72b3327
https://doi.org/10.1002/ejhf.2874
https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2874
https://doi.org/10.1002/ejhf.2874
https://hdl.handle.net/2434/980550
https://doi.org/10.1002/ejhf.2874
https://resolver.sub.uni-goettingen.de/purl?gro-2/127436
https://pergamos.lib.uoa.gr/uoa/dl/object/3340628
https://avesis.deu.edu.tr/publication/details/fe8e8638-4784-41d0-a0a6-820a71d0303c/oai
https://curis.ku.dk/ws/files/360065011/IKM_European_J_of_Heart_Fail_2023_Metra_Worsening_of_chronic_heart_failure_definition_epidemiology_management_and.pdf
https://hdl.handle.net/11379/577550
https://doi.org/10.1002/ejhf.2874
https://hdl.handle.net/11588/921932
https://doi.org/10.1002/ejhf.2874 -
9
Authors: et al.
Source: ESC Heart Fail
ESC Heart Failure, Vol 10, Iss 3, Pp 1745-1756 (2023)
Jensen, J, Poulsen, M K, Petersen, P W, Gerdes, B, Rossing, K & Schou, M 2023, ' Prevalence of heart failure phenotypes and current use of therapies in primary care : results from a nationwide study ', ESC heart failure, vol. 10, no. 3, pp. 1745-1756 . https://doi.org/10.1002/ehf2.14324Subject Terms: Heart Failure, Primary Health Care, Adrenergic beta-Antagonists, Heart failure, Angiotensin-Converting Enzyme Inhibitors, Stroke Volume, Original Articles, Heart Failure/drug therapy, Adrenergic beta-Antagonists/therapeutic use, Primary care, Angiotensin Receptor Antagonists/therapeutic use, 3. Good health, Treatment, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Phenotypes, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, RC666-701, Prevalence, Diseases of the circulatory (Cardiovascular) system, Humans
File Description: application/pdf
-
10
Authors: et al.
Source: Moledina, S M, Mannan, F, Weight, N, Elbadawi, A, Elgendy, I Y & Fischman, D L 2022, ' Impact of QRS Duration on Non-ST-Segment Elevation Myocardial Infarction (from a National Registry) ', The American journal of cardiology, vol. 183, pp. 1-7 . https://doi.org/10.1016/j.amjcard.2022.07.039
Subject Terms: Aspirin, Myocardial Infarction, Angiotensin-Converting Enzyme Inhibitors, 3. Good health, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, 03 medical and health sciences, Non-ST Elevated Myocardial Infarction/diagnosis, Percutaneous Coronary Intervention, Treatment Outcome, 0302 clinical medicine, Myocardial Infarction/epidemiology, Humans, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/epidemiology, Registries, Non-ST Elevated Myocardial Infarction, Percutaneous Coronary Intervention/adverse effects, Aged
Access URL: https://pubmed.ncbi.nlm.nih.gov/36100505
-
11
Authors: et al.
Contributors: et al.
Source: Cardiol J
Subject Terms: Male, hypertension, Antihypertensive Agents / adverse effects, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Clinical Cardiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects, LDL, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Risk Factors, Humans, Hypertension* / drug therapy, Rosuvastatin Calcium, renin–angiotensin system, rosuvastatin calcium, Antihypertensive Agents, Aged, hypercholesterolemia, Angiotensin Receptor Antagonists / therapeutic use, Cholesterol, LDL, 3. Good health, Drug Combinations, Cholesterol, Hypertension* / diagnosis, Combination, Hypertension, Rosuvastatin Calcium / adverse effects, Drug Therapy, Combination, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Access URL: https://journals.viamedica.pl/cardiology_journal/article/download/CJ.a2020.0167/52588
https://pubmed.ncbi.nlm.nih.gov/33346375
https://journals.viamedica.pl/cardiology_journal/article/download/CJ.a2020.0167/52588
https://journals.viamedica.pl/cardiology_journal/article/view/CJ.a2020.0167/52588
https://www.ncbi.nlm.nih.gov/pubmed/33346375
https://pubmed.ncbi.nlm.nih.gov/33346375/ -
12
Authors: et al.
Contributors: et al.
Source: Butt, J H, Dewan, P, Jhund, P S, Anand, I S, Atar, D, Ge, J, Desai, A S, Echeverria, L E, Køber, L, Lam, C S P, Maggioni, A P, Martinez, F, Packer, M, Rouleau, J L, Sim, D, Van Veldhuisen, D J, Vrtovec, B, Zannad, F, Zile, M R, Gong, J, Lefkowitz, M P, Rizkala, A R, Solomon, S D & McMurray, J J V 2022, ' Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction ', Journal of the American College of Cardiology, vol. 80, no. 12, pp. 1130-1143 . https://doi.org/10.1016/j.jacc.2022.06.037
Subject Terms: heart failure, Tetrazoles, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, frailty, outcomes, Aminobutyrates/pharmacology, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, Humans, Heart Failure, Frailty, Aminobutyrates, Biphenyl Compounds, clinical trial, Stroke Volume, Biphenyl Compounds/therapeutic use, Heart Failure/drug therapy, Tetrazoles/pharmacology, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Drug Combinations, Valsartan
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/36050227
https://eprints.gla.ac.uk/278273/1/278273.pdf
https://hal.univ-lorraine.fr/hal-03794790v1
https://doi.org/10.1016/j.jacc.2022.06.037
https://hal.univ-lorraine.fr/hal-03794790v1/document
https://curis.ku.dk/ws/files/345425679/1_s2.0_S0735109722055966_main.pdf -
13
Authors: et al.
Contributors: et al.
Source: Stroke. 53:1837-1846
Subject Terms: hypertension, Angiotensins, [SDV]Life Sciences [q-bio], renin-angiotensin system, Angiotensin-Converting Enzyme Inhibitors, Sciences de la santé humaine, Stroke/epidemiology, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, Hypertension/epidemiology, Neurologie, ischemic stroke, Humans, Human health sciences, Antihypertensive Agents, Ischemic Stroke, Advanced and Specialized Nursing, Antihypertensive Agents/therapeutic use, Hypertension/chemically induced, Hypertension/drug therapy, blood pressure, 3. Good health, [SDV] Life Sciences [q-bio], Stroke, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Treatment Outcome, Neurology, thrombectomy, Intracranial Hemorrhages/chemically induced, Hypertension, Neurology (clinical), Cardiology and Cardiovascular Medicine, Intracranial Hemorrhages
-
14
Authors: et al.
Source: INTERNATIONAL JOURNAL OF CARDIOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Docusalut
Conselleria de Salut i Consum del Govern de les Illes BalearsSubject Terms: Propensity Score, Male, Time Factors, Resultado del Tratamiento, Anciano, Heart Failure* / drug therapy, Angiotensin-Converting Enzyme Inhibitors, Enfermedad Aguda, Hospital Mortality* / trends, Cohort Studies, Renin-Angiotensin System, Angiotensin Receptor Antagonists, Emergency Service, Hospital, Renin-Angiotensin System / drug effects, Angiotensin-converting enzyme inhibitors, Angiotensin-Converting Enzyme Inhibitors* / therapeutic use, Servicio de Urgencia en Hospital, Humans, Heart Failure* / epidemiology, Heart Failure* / mortality, Hospital Mortality, Mortality, Masculino, Aged, Heart Failure, Aged, 80 and over, Angiotensin Receptor Antagonists* / therapeutic use, Spain / epidemiology, Emergency department, Femenino, Acute heart failure, Puntaje de Propensión, Angiotensin receptor blockers, Humanos, Treatment Outcome, Spain, Acute Disease, Female, Factores de Tiempo
File Description: application/pdf
-
15
Authors: et al.
Contributors: et al.
Source: Hypertension Research. 45:758-768
Subject Terms: Antihypertensive Agents / therapeutic use, Adrenergic beta-Antagonists, Myocardial Infarction, Angiotensin-Converting Enzyme Inhibitors, Diuretics / therapeutic use, Adrenergic beta-Antagonists / therapeutic use, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, Humans, Calcium Channel Blockers / therapeutic use, Hypertension* / chemically induced, Diuretics, Antihypertensive Agents, Angiotensin Receptor Antagonists / therapeutic use, Stroke* / chemically induced, Cardiovascular risk, Monotherapy, Prognosis, Calcium Channel Blockers, 3. Good health, Stroke, Stroke* / prevention & control, Myocardial Infarction* / chemically induced, Hypertension, Angiotensin-Converting Enzyme Inhibitors / therapeutic use, Stroke* / drug therapy
Access URL: https://pubmed.ncbi.nlm.nih.gov/35338336
-
16
Authors: et al.
Source: Eur J Cancer
European journal of cancer, vol. 163, pp. 108-118Subject Terms: Male, 0301 basic medicine, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Antihypertensive Agents/pharmacology, Antihypertensive Agents/therapeutic use, Humans, Hypertension/chemically induced, Hypertension/drug therapy, Immune Checkpoint Inhibitors/adverse effects, Prospective Studies, Renin-Angiotensin System, Retrospective Studies, ACEI, ARB, Immune checkpoint inhibitors, Immune therapy, Renin–angiotensin–aldosterone system blocker, Angiotensin-Converting Enzyme Inhibitors, Article, 3. Good health, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, Hypertension, Immune Checkpoint Inhibitors, Antihypertensive Agents
File Description: application/pdf
Access URL: http://www.ejcancer.com/article/S0959804921013058/pdf
https://pubmed.ncbi.nlm.nih.gov/35065368
https://serval.unil.ch/notice/serval:BIB_79B502336559
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_79B5023365590
https://serval.unil.ch/resource/serval:BIB_79B502336559.P001/REF.pdf -
17
Authors:
Subject Terms: Proteins -- Methylation, Methyltransferases, Drug resistance in cancer cells, Cancer -- Chemotherapy, Enzyme Inhibitors -- Therapeutic use, Precision medicine
Relation: Micallef, I., Fenech, K., & Baron, B. (2024). Therapeutic targeting potential of the protein lysine and arginine methyltransferases to reverse cancer chemoresistance. Frontiers in Molecular Biosciences, 11, 1455415.; https://www.um.edu.mt/library/oar/handle/123456789/138157
-
18
Authors: et al.
Source: Spiliopoulou, P, Kazmi, F, Aroldi, F, Holmes, T, Thompson, D, Griffiths, L, Qi, C, Parkes, M, Lord, S, Veal, G J, Harrison, D J, Coyle, V M, Graham, J, Jeffry Evans, T R & Blagden, S P 2024, 'A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)', Journal of Experimental and Clinical Cancer Research, vol. 43, no. 1, pp. 100. https://doi.org/10.1186/s13046-024-03010-1
Subject Terms: Humans, Floxuridine/therapeutic use, Thymidylate Synthase/therapeutic use, Neoplasms/pathology, Fluorouracil/adverse effects, Enzyme Inhibitors/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects
-
19
Authors: et al.
Source: Open heart, vol. 11, no. 2
Subject Terms: Humans, Atrial Fibrillation/drug therapy, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Female, Male, Aged, Prospective Studies, Sex Factors, Adrenergic beta-Antagonists/administration & dosage, Adrenergic beta-Antagonists/adverse effects, Risk Factors, Middle Aged, Switzerland/epidemiology, Treatment Outcome, Follow-Up Studies, Risk Assessment/methods, Angiotensin-Converting Enzyme Inhibitors/administration & dosage, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Time Factors, Heart Failure/diagnosis, Heart Failure/physiopathology, 80 and over, Arrhythmias, Cardiac, Atrial Fibrillation, Heart Failure
File Description: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39134361; info:eu-repo/semantics/altIdentifier/pissn/2053-3624; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4214CB4209629; https://serval.unil.ch/notice/serval:BIB_4214CB420962; https://serval.unil.ch/resource/serval:BIB_4214CB420962.P001/REF.pdf
-
20
Authors: et al.
Contributors: et al.
Source: Trials
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Stoelinga, A E C, Tushuizen, M E, van den Hout, W B, Girondo, M D M R, de Vries, E S, Levens, A D, Moes, D-J A R, Gevers, T J G, van der Meer, S, Brouwer, H T, de Jonge, H J M, de Boer, Y S, Beuers, U H W, van der Meer, A J & on behalf of the Dutch Autoimmune Hepatitis Group 2024, 'Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study) : a study protocol for a phase III, open-label, multicentre, randomised controlled trial', Trials, vol. 25, no. 1, 61. https://doi.org/10.1186/s13063-023-07832-w
Trials, 25, 1Subject Terms: Liver Cirrhosis, Medicine (General), Complete biochemical response, Medicine (miscellaneous), Randomised controlled trials, DIAGNOSIS, Autoimmune hepatitis, Tacrolimus, Study Protocol, KIDNEY, R5-920, SDG 3 - Good Health and Well-being, AIH, MOFETIL, FIBROSIS, CRITERIA, Humans, Multicenter Studies as Topic, Pharmacology (medical), Enzyme Inhibitors, Retrospective Studies, Randomized Controlled Trials as Topic, Enzyme Inhibitors/therapeutic use [MeSH], Humans [MeSH], Mycophenolate mofetil, Treatment Outcome [MeSH], Tacrolimus/adverse effects [MeSH], Retrospective Studies [MeSH], Multicenter Studies as Topic [MeSH], Autoimmune liver disease, Clinical Trials, Phase III as Topic [MeSH], Randomized Controlled Trials as Topic [MeSH], Hepatitis, Autoimmune/drug therapy [MeSH], Second-line treatment, Quality of Life [MeSH], Liver Cirrhosis/drug therapy [MeSH], Hepatitis, Autoimmune/diagnosis [MeSH], Immunosuppressive Agents/adverse effects [MeSH], Mycophenolic Acid/adverse effects [MeSH], TRANSIENT ELASTOGRAPHY, INDUCTION, Mycophenolic Acid, EFFICACY, 3. Good health, Hepatitis, Autoimmune, Treatment Outcome, Clinical Trials, Phase III as Topic, Quality of Life, Gastroenterology - Radboud University Medical Center, BIOCHEMICAL REMISSION, 2ND-LINE, Immunosuppressive Agents
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38233878
https://doaj.org/article/e9871b3711e44943a5adbb67b77352b2
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/302923
https://research.vumc.nl/en/publications/9c1ec736-b7c2-4190-b7a6-2a4e474c1510
https://dspace.library.uu.nl/handle/1874/453842
https://repository.ubn.ru.nl//bitstream/handle/2066/302923/302923.pdf
https://hdl.handle.net/2066/302923
https://repository.publisso.de/resource/frl:6501558
https://hdl.handle.net/1887/3720971
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text